Gordon Auyeung
Family Medicine · New York, NYNPI 1043741291
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $606, more than ten times the $27 reported in 2019.
Across 103 payments — averaging $20.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$337
- Novo Nordisk$245
- Amarin Pharma, Inc.$198
- Pfizer$167
- Boehringer Ingelheim$163
- GSK$114
- plus $874 from 15 others
What the payments were for
- Food & beverage$2,07899%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 19 | $337 |
| Novo Nordisk | 11 | $245 |
| Amarin Pharma, Inc. | 9 | $198 |
| Pfizer | 6 | $167 |
| Boehringer Ingelheim | 7 | $163 |
| GSK | 6 | $114 |
| Biogen | 6 | $114 |
| Merck | 5 | $111 |
| Amgen | 6 | $108 |
| AbbVie | 4 | $82 |
| Esperion Therapeutics, Inc. | 4 | $77 |
| Lilly USA, LLC | 3 | $71 |
| Bayer | 3 | $60 |
| Seqirus USA Inc | 3 | $54 |
| IBSA Pharma Inc. | 2 | $46 |
| Kowa Pharmaceuticals America, Inc. | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Intra-sana Laboratories | 1 | $28 |
| Genentech USA, Inc. | 2 | $27 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
How this compares
$2,098 in reported general payments places this provider in the 75th percentile of 4,321 family medicine providers in New York.
Other family medicine in New York
- Matthew PabisNew York$222K
- Eric BatesNew York$171K
- Alexander BlinskiNew York$159K
- Jason KindtNew York$122K
- Mahyar EidgahNew York$76K
- Anthony LyonNew York$65K
- Daniel BowersNew York$44K
- Angelina LauchangcoNew York$26K
- Orin DouglasNew York$25K
- Punyadech PhotangthamNew York$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.